BioRestorative Therapies Inc Share Price Today: Live Updates & Key Insights

BioRestorative Therapies Inc share price today is $0.2789, up 9.25%. The stock opened at $0.2602 against the previous close of $0.2562, with an intraday high of $0.288 and low of $0.254.

BioRestorative Therapies Inc Share Price Chart

BioRestorative Therapies Inc

us-stock
To Invest in {{usstockname}}
us-stock

BioRestorative Therapies Inc Share Price Performance

$0.2789 0.0925(9.25%) BRTX at 23 Mar 2026 12:18 PM Biotechnology
Lowest Today 0.254
Highest Today 0.288
Today’s Open 0.2602
Prev. Close 0.2562
52 Week High 2.10
52 Week Low 0.19
Day’s Range: Low 0.254 High 0.288
52-Week Range: Low 0.19 High 2.10
1 day return -
1 Week return -9.61
1 month return +30.0
3 month return -76.46
6 month return -82.02
1 year return -86.35
3 year return -92.05
5 year return -96.31
10 year return -

BioRestorative Therapies Inc Institutional Holdings

Vanguard Group Inc 0.41

Geode Capital Management, LLC 0.27

Vanguard Institutional Extnd Mkt Idx Tr 0.23

Wealth Alliance, LLC 0.19

StoneX Group Inc 0.17

Fidelity Extended Market Index 0.14

Citadel Advisors Llc 0.14

Virtu Financial LLC 0.11

State Street Corp 0.09

Fidelity Total Market Index 0.06

TWO SIGMA SECURITIES, LLC 0.05

Fidelity Series Total Market Index 0.04

Fidelity Nasdaq Composite Index 0.02

Spartan Total Market Index Pool G 0.02

Northern Trust Extended Eq Market Idx 0.01

NT Ext Equity Mkt Idx Fd - L 0.01

Advisor Group Holdings, Inc. 0.01

Tower Research Capital LLC 0.01

Wells Fargo & Co 0.00

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.00

SBI Securities Co Ltd 0.00

Spartan Extended Market Index Pool F 0.00

Bank of America Corp 0.00

Citigroup Inc 0.00

Morgan Stanley - Brokerage Accounts 0.00

Newman Dignan & Sheerar Inc 0.00

TD Waterhouse Canada Inc 0.00

UBS Group AG 0.00

BioRestorative Therapies Inc Market Status

Strong Buy: 1

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

BioRestorative Therapies Inc Fundamentals

Market Cap 6.05 M

PB Ratio 2.542

PE Ratio 0.0

Enterprise Value -7.46 M

Total Assets 12.28 M

Volume 4846604

BioRestorative Therapies Inc Company Financials

Annual Revenue FY24:145800 0.1M, FY23:130200 0.1M, FY22:119800 0.1M, FY21:46000 0.0M, FY20:130000 0.1M

Annual Profit FY24:145800 0.1M, FY23:null 0.0M, FY22:119800 0.1M, FY21:46000 0.0M, FY20:130000 0.1M

Annual Net worth FY24:-10417704 -10.4M, FY23:-15937819 -15.9M, FY22:-18015513 -18.0M, FY21:-29938605 -29.9M, FY20:-17921113 -17.9M

Quarterly Revenue Q3/2025:11800 0.0M, Q2/2025:303300 0.3M, Q1/2025:25000 0.0M, Q3/2024:233600 0.2M, Q2/2024:89100 0.1M

Quarterly Profit Q3/2025:-51390 -0.1M, Q2/2025:294571 0.3M, Q1/2025:22091 0.0M, Q3/2024:215357 0.2M, Q2/2024:82610 0.1M

Quarterly Net worth Q3/2025:-3038277 -3.0M, Q2/2025:-2656263 -2.7M, Q1/2025:-5339799 -5.3M, Q3/2024:-1091416 -1.1M, Q2/2024:-4028562 -4.0M

About BioRestorative Therapies Inc & investment objective

Company Information BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. It develops programs relate to the treatment of disc/spine disease and metabolic disorders. The company's products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure; and ThermoStem, a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. It also operates a commercial biocosmeceutical platform. In addition, the company provides investigational curved needle device to deliver cells and/or other therapeutic products or material to the spine and discs, and other parts of the body. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. is headquartered in Melville, New York.

Organisation Biotechnology

Employees 11

Industry Biotechnology

CEO Mr. Lance Alstodt

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

BioRestorative Therapies Inc FAQs

What is the share price of BioRestorative Therapies Inc today?

The current share price of BioRestorative Therapies Inc is $0.2789.

Can I buy BioRestorative Therapies Inc shares in India?

Yes, Indian investors can buy BioRestorative Therapies Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy BioRestorative Therapies Inc shares in India?

You can easily invest in BioRestorative Therapies Inc shares from India by:

Can I buy fractional shares of BioRestorative Therapies Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of BioRestorative Therapies Inc?

BioRestorative Therapies Inc has a market cap of $6.05 M.

In which sector does BioRestorative Therapies Inc belong?

BioRestorative Therapies Inc operates in the Biotechnology sector.

What documents are required to invest in BioRestorative Therapies Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of BioRestorative Therapies Inc?

The PE ratio of BioRestorative Therapies Inc is N/A and the PB ratio is 2.54.